Theme lead: Professor Ravindra K Gupta
Ravi Gupta is Professor of Clinical Microbiology at Cambridge University.
Ravi has worked in HIV drug resistance both at molecular and population levels, and his work led to change in WHO treatment guidelines for HIV.
He led the study demonstrating HIV cure in the ‘London Patient’ – the world’s only living HIV cure, and the second recorded in history.
During the COVID-19 pandemic Ravi deployed his expertise in RNA virus genetics and biology to report that SARS-CoV-2 variants likely arise in immune-compromised individuals who are also at greatest risk of severe disease.
More recently Ravi defined the replication advantage of the Delta variant and the tropism shift and immune escape of Omicron, explaining why this variant is less severe.
In addition his group has defined reasons behind poorer vaccine responses in the elderly. Ravi has advised the UK government on COVID-19 through SAGE and NERVTAG and in 2020 appeared in the list of 100 most influential people by TIME and in 2022 was named in the worldwide list of most highly cited researchers by Clarivate Analytics.
||Theme Co-lead, Director of Global Health at Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID)||email@example.com|
||Theme lead, Immunity, Inflammation and Transplantation
|Ken Smith||Professor of Medicine, Head of the Department of Medicine at the University of Cambridgefirstname.lastname@example.org|
||Theme lead, Data Science and Population Healthemail@example.com|
||Professor of Respiratory Biology, Research Director of the Cambridge Centre for Lung Infectionfirstname.lastname@example.org|
|Daniela De Angelis
||Professor of Statistical Science for Health, Programme Leader at the Medical Research Council
||Professor of Immunology and Infectious Diseasesemail@example.com|
|Sharon Peacock CBE||Professor of Public Health and Microbiology, Executive Director and Chair of the COVID-19 Genomics UK (COG-UK) firstname.lastname@example.org|